Literature DB >> 24426346

Acute promyelocytic leukemia presenting as ischemic stroke in young.

Rajan Kapoor1, H P Pati1, Sanjeev Kumar Gupta1, Nitin Gupta1.   

Abstract

Coagulopathy in acute promyelocytic leukemia (APL) is a very complex disorder and is believed to result from interplay of various factors. Usually patients present with bleeding tendencies which can be life threatening. However, a few present with thromboses. Here, we report a young male with APL who presented with ischemic stroke in young.

Entities:  

Year:  2012        PMID： 24426346      PMCID： PMC3636346          DOI： 10.1007/s12288-012-0145-z

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


  19 in total

1.  Coronaric thrombotic events in acute promyelocytic leukemia during all-trans retinoic acid treatment: a role for adhesion molecules overexpression?

Authors:  C Torromeo; R Latagliata; G Avvisati; M C Petti; F Mandelli
Journal:  Leukemia       Date:  1999-02       Impact factor: 11.528

2.  Reversible portal vein thrombosis complicating induction therapy of acute promyelocytic leukemia.

Authors:  M Colović; P Miljić; N Colović; G Janković; M Stojković
Journal:  Thromb Res       Date:  2001-01-15       Impact factor: 3.944

3.  Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features.

Authors:  M Breccia; G Avvisati; R Latagliata; I Carmosino; A Guarini; M S De Propris; F Gentilini; M C Petti; G Cimino; F Mandelli; F Lo-Coco
Journal:  Leukemia       Date:  2006-08-24       Impact factor: 11.528

4.  All-trans retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukaemia.

Authors:  J E Brown; A Olujohungbe; J Chang; W D Ryder; G R Morganstern; R Chopra; J H Scarffe
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

5.  Annexin II and bleeding in acute promyelocytic leukemia.

Authors:  J S Menell; G M Cesarman; A T Jacovina; M A McLaughlin; E A Lev; K A Hajjar
Journal:  N Engl J Med       Date:  1999-04-01       Impact factor: 91.245

6.  Acute promyelocytic leukemia with ischaemic events.

Authors:  T A Quadir; B N Dhabhar; A K Dhar; U P Hedge; R V Shah; A B Pathak; S H Advani
Journal:  J Assoc Physicians India       Date:  1993-05

Review 7.  Coagulopathy of acute promyelocytic leukemia.

Authors:  A Falanga; T Barbui
Journal:  Acta Haematol       Date:  2001       Impact factor: 2.195

8.  Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage.

Authors:  S Hashimoto; T Koike; W Tatewaki; Y Seki; N Sato; T Azegami; N Tsukada; H Takahashi; H Kimura; M Ueno
Journal:  Leukemia       Date:  1994-07       Impact factor: 11.528

Review 9.  Extensive splenic infarction, deep vein thrombosis and pulmonary emboli complicating induction therapy with all-trans-retinoic acid (ATRA) for acute promyelocytic leukemia.

Authors:  Neta Goldschmidt; Alexander Gural; Dina Ben Yehuda
Journal:  Leuk Lymphoma       Date:  2003-08

Review 10.  Acute promyelocytic leukemia.

Authors:  R P Warrell; H de Thé; Z Y Wang; L Degos
Journal:  N Engl J Med       Date:  1993-07-15       Impact factor: 91.245
View more
  1 in total

1.  Unusual Presentation of Acute Leukaemia: A Tripod of Cases.

Authors:  Manjari Kishore; Vijay Kumar; Sadhna Marwah; Abhay S Nigam
Journal:  J Clin Diagn Res       Date:  2016-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.